Home
JSPR

JSPR

Jasper Therapeutics Inc.

as of 12-12-2025 3:46pm EST

$1.81

$0.04

-1.90%

Stocks Health Care Biotechnology: Biological Products (No Diagnostic Substances) Nasdaq

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

#24 in Best Uptrend Penny Stocks

Chart Type:

Time Range:

Founded:	2018	Country:	United States
Employees:	N/A	City:	REDWOOD CITY
Market Cap:	68.4M	IPO Year:	N/A
Target Price:	$25.60	AVG Volume (30 days):	3.8M
Analyst Decision:	Buy	Number of Analysts:	12
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	-5.79	EPS Growth:	N/A
52 Week Low/High:	$1.39 - $23.11	Next Earning Date:	11-10-2025
Revenue:	N/A	Revenue Growth:	N/A
Revenue Growth (this year):	N/A	Revenue Growth (next year):	N/A

AI-Powered JSPR Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold

Model Accuracy: 72.19%

72.19%

Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

View Full JSPR Forecast & Prediction with Hourly Data

Compare JSPR vs Leading Stocks

See how JSPR stacks up against similar companies in the market

Share on Social Networks:

Tools & Resources

Enhance your trading experience with our free tools

Free JSPR Stock Widget

Embed our interactive stock ticker widget on your website for real-time updates.

Free Tool

Stock Alerts on Telegram

Get instant notifications, market insights, and expert analysis delivered to your phone.

Live Updates

Disclaimer

The information presented on this page, "JSPR Jasper Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.